Nutritionally variant streptococci: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
Line 14: Line 14:
 
== Management ==
 
== Management ==
   
* Susceptibilities shown below are from one small study[[CiteRef::kanamoto2018an]]
+
* Susceptibilities shown below are from several studies[[CiteRef::kanamoto2018an]][[CiteRef::patel2017an]][[CiteRef::mushtaq2016di]]
   
 
{| class="wikitable"
 
{| class="wikitable"
Line 23: Line 23:
 
|-
 
|-
 
|Penicillin
 
|Penicillin
|57%
+
|14 to 57%
|82%
+
|34 to 82%
|100%
+
|80 to 100%
 
|-
 
|-
 
|Ampicillin
 
|Ampicillin
Line 43: Line 43:
 
|-
 
|-
 
|Ceftriaxone
 
|Ceftriaxone
|100%
+
|92 to 100%
|76%
+
|22 to 76%
|100%
+
|90 to 100%
 
|-
 
|-
 
|Ceftazidime
 
|Ceftazidime
Line 56: Line 56:
 
|100%
 
|100%
 
|100%
 
|100%
  +
|-
  +
|Meropenem
  +
|72 to 81%
  +
|87 to 95%
  +
|91%
 
|-
 
|-
 
|Gentamicin
 
|Gentamicin
Line 66: Line 71:
 
|18%
 
|18%
 
|17%
 
|17%
  +
|-
  +
|Levofloxacin
  +
|100%
  +
|97 to 100%
  +
|92%
 
|-
 
|-
 
|Minocycline
 
|Minocycline
Line 75: Line 85:
 
|100%
 
|100%
 
|100%
 
|100%
|83%
+
|83 to 100%
 
|-
 
|-
 
|TMP-SMX
 
|TMP-SMX

Latest revision as of 15:28, 11 March 2022

Background

  • Require pyridoxine (vitamin B6) supplementation to group
  • Also called pyridoxal-dependent or stalliting streptococci

Organisms

Clinical Manifestations

Management

  • Susceptibilities shown below are from several studies123
Antibiotic Abiotrophia defectiva Granulicatella adiacens Granulicatella elegans
Penicillin 14 to 57% 34 to 82% 80 to 100%
Ampicillin 86% 100% 100%
Piperacillin 0% 53% 100%
Cefazolin 29% 88% 100%
Ceftriaxone 92 to 100% 22 to 76% 90 to 100%
Ceftazidime 0% 0% 50%
Imipenem 100% 100% 100%
Meropenem 72 to 81% 87 to 95% 91%
Gentamicin 0% 0% 0%
Ciprofloxacin 100% 18% 17%
Levofloxacin 100% 97 to 100% 92%
Minocycline 57% 94% 100%
Vancomycin 100% 100% 83 to 100%
TMP-SMX 14% 0% 17%

References

  1. ^  Taisei Kanamoto, Shigemi Terakubo, Hideki Nakashima. Antimicrobial Susceptibilities of Oral Isolates of Abiotrophia and Granulicatella According to the Consensus Guidelines for Fastidious Bacteria. Medicines. 2018;5(4):129. doi:10.3390/medicines5040129.